The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
OpinionToday’s drug patent monopolies are stronger than at any point in the last century, raising prescription prices, reports Tahir Amin...
-
39 developing countries excluded from optimal HIV treatment – a dangerous oversight or deliberate tactic?
OpinionThis World AIDS Day (1 December 2017), we’re pleased to have reached a point where more people are set to...
-
“We want dolutegravir for all, and we want it now.”
OpinionArticle first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...
Read more about “We want dolutegravir for all, and we want it now.”
